Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #16
    By the way: The effect of seeing a large count for a gene in one sample and zero counts in all other samples is quite common when working with sample derived from very few cells.

    In such cases, it is not too uncommon that one only gets maybe around a million mRNA molecules per sample, and after reverse transcription, this is down to possibly less than a hundred thousand cDNA molecules, which then go through many rounds of PCR. If one then sequences this to a depth of a few million reads per sample, i.e., much more reads than there were initial cDNA molecules, then one is bound to see most transcript molecules several times and some individual cDNA molecules, which fared especially well in the PCR, can easily produce hundreds of reads, all showing fragments of the very same mRNA molecule.

    Hence, in a setting with very low amounts of starting RNA (typically, below ~1 µg of total RNA per sample), it is quite possible to see a huge difference, say hundreds of reads in one sample and zero reads for the same gene in all other samples, and in reality, this reflects a difference of only a single lone mRNA molecule.

    See also our paper on this issue:
    Brenencke, Anders, Kim et al., Accounting for technical noise in single-cell RNA-seq experiments
    Nature Methods, 10, 1093–1095 (2013)
    doi:10.1038/nmeth.2645
    Last edited by Simon Anders; 05-23-2014, 04:15 AM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...